Conditions: Chronic Hepatitis C
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 109
Healthy volunteers: no

Brief summary:
This study will evaluate the efficacy and safety of MP-424 with Peginterferon Alfa-2b (PEG-IFN) and Ribavirin (RBV) in patients with (Genotype 1) hepatitis C, who relapsed after previous treatment.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: MP-424 intervention 2: Ribavirin intervention 3: Peginterferon Alfa-2b
Intervention descriptions: intervention 1: 750 mg every 8 hours for 12 weeks intervention 2: 600 - 1000 mg/day based on body weight for 24 weeks intervention 3: 1.5 mcg/kg/week for 24 weeks

Protocol document: